Copyright
©The Author(s) 2024.
World J Diabetes. Mar 15, 2024; 15(3): 502-518
Published online Mar 15, 2024. doi: 10.4239/wjd.v15.i3.502
Published online Mar 15, 2024. doi: 10.4239/wjd.v15.i3.502
Figure 1 Jianpi Gushen Huayu Decoction administration improved body weight loss, hyperglycemia, and kidney injury in diabetic nephropathy mice.
A: Curves of body weight changes; B: Curves of fasting blood glucose changes; C: Creatinine levels; D: Blood urea nitrogen level; E: 24 h urine total protein levels. Control, model, irbesartan, low-dose Jianpi Gushen Huayu Decoction (JPGSL), medium-dose JPGS, and high-dose JPGS groups, n = 10 per group. bP < 0.01 as compared to the control group; cP < 0.05 as compared to the model group; dP < 0.01 as compared to the model group. JPGS: Jianpi Gushen Huayu Decoction; FBG: Fasting blood glucose; Cr: Creatinine; BUN: Blood urea nitrogen; 24h-UTP: 24 h urine total protein; JPGSL: Low-dose Jianpi Gushen Huayu Decoction; JPGSM: Medium-dose Jianpi Gushen Huayu Decoction; JPGSH: High-dose Jianpi Gushen Huayu Decoction; IRBE: Irbesartan.
- Citation: Ma ZA, Wang LX, Zhang H, Li HZ, Dong L, Wang QH, Wang YS, Pan BC, Zhang SF, Cui HT, Lv SQ. Jianpi Gushen Huayu decoction ameliorated diabetic nephropathy through modulating metabolites in kidney, and inhibiting TLR4/NF-κB/NLRP3 and JNK/P38 pathways. World J Diabetes 2024; 15(3): 502-518
- URL: https://www.wjgnet.com/1948-9358/full/v15/i3/502.htm
- DOI: https://dx.doi.org/10.4239/wjd.v15.i3.502